NEW DELHI (Reuters) – The Serum institute of India will raise production of the AstraZeneca COVID-19 vaccine to about 90 million doses in June from about 65 million a month now, a company spokesman told Reuters on Monday.
(Reporting by Krishna N. Das; Editing by Himani Sarkar)
